Verano Holdings (VRNO) Other Working Capital Changes (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Other Working Capital Changes of $3.6 million for Q1 2026, down 21.44% year-over-year from $4.5 million in Q1 2025, and down 66.06% quarter-over-quarter from $10.5 million in Q4 2025.
Verano Holdings (VRNO) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Other Working Capital Changes for 6 consecutive years, with $3.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 21.44% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $17.8 million (down 6.44% YoY), while the FY2025 annual figure was $18.8 million, up 19.68% from the prior year.
- Other Working Capital Changes declined to $3.6 million in Q1 2026 per VRNO's latest filing, from $10.5 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $22.4 million in Q4 2022 and bottomed at -$10.1 million in Q1 2024.
- Historically, Other Working Capital Changes has averaged $893117.6 across 5 years, with a median of -$47000.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 93.56% — and 2023, when it jumped 1102.52%.
- Verano Holdings' Other Working Capital Changes stood at $5.4 million in 2022, then sank by 62.19% to $2.0 million in 2023, then soared by 260.46% to $7.3 million in 2024, then surged by 43.71% to $10.5 million in 2025, then tumbled by 66.06% to $3.6 million in 2026.
- Business Quant data shows VRNO's Other Working Capital Changes at $3.6 million in Q1 2026, $10.5 million in Q4 2025, and $854000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Verano Holdings | 433.71 Mn | 348.51 Mn | 99.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.69 Mn |
| Jun 30, 2026 | 1.69 Mn |
| Jun 30, 2026 | 1.69 Mn |
| Mar 31, 2026 | -8.61 Mn |
| Mar 31, 2026 | -8.61 Mn |
| Mar 31, 2026 | -8.61 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Sep 30, 2025 | -3.48 Mn |
| Sep 30, 2025 | -3.48 Mn |
| Sep 30, 2025 | -3.48 Mn |
| Jun 30, 2025 | 561,000.00 |
| Jun 30, 2025 | 561,000.00 |
| Jun 30, 2025 | 561,000.00 |
| Mar 31, 2025 | 1.32 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | -1.49 Mn |
| Dec 31, 2024 | -1.49 Mn |